A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a Regimen

Author： de Gramont A.   Louvet C.   Andre T.   Tournigand C.   Krulik M.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.5, 1998-04, pp. : 619-626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

By Andre T.   Louvet C.   Maindrault-Goebel F.   Couteau C.   Mabro M.   Lotz J.P.   Gilles-Amar V.   Krulik M.   Carola E.   Izrael V.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1343-1347

Elsevier

Access to resources Recommend Favorite

Oxaliplatin with High-dose Leucovorin and 5-Fluorouracil 48-hour Continuous Infusion in Pretreated Metastatic Colorectal Cancer

By de Gramont A.   Vignoud J.   Tournigand C.   Louvet C.   Andre T.   Varette C.   Raymond E.   Moreau S.   Le Bail N.   Krulik M.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 214-219

Elsevier

Access to resources Recommend Favorite

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

By Maindrault-Goebel F.   Louvet C.   Andre T.   Carola E.   Lotz J.P.   Molitor J.L.   Garcia M.L.   Gilles-Amar V.   Izrael V.   Krulik M.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1338-1342

Elsevier

Access to resources Recommend Favorite

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

By Maindrault-Goebel F.   de Gramont A.   Louvet C.   Andre T.   Carola E.   Mabro M.   Artru P.   Gilles V.   Lotz J.P.   Izrael V.   Krulik M.   for the Oncology Multidisciplinary Research Group GERCOR  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1000-1005

Elsevier

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen

By Raderer M.   Kornek G.V.   Hejna M.H.L.   Miholic J.   Weinlaender G.   Brodowicz T.   Fiebiger W.C.C.   Valencak J.B.   Scheithauer W.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1128-1130

Elsevier

Access to resources Recommend Favorite